Investor Lists

Series B genomics investors

Updated 7 November 2026

Firms we have watched take part in a Series B round raised by a genomics company in the last two years. Both the stage and the sector are what they did, not what their website says.

See all 78 →The top 25
78investors on the listNo change this week
2,205cheques in 12 months+12% against the market
$39Mmedian round they joined+391% against the market median
90%wrote a cheque in 12 months
78%have led a round

The Top 25

Ordered by cheques observed, never by anything anyone paid for

Deploying now (25)

  1. 1Andreessen HorowitzDeploying nowVC firm · United States1,661$27Mmedian roundNov 2026last seen
  2. 2New Enterprise AssociatesDeploying nowVC firm · United States1,610$34Mmedian roundOct 2026last seen
  3. 3General CatalystDeploying nowVC firm · United States1,387$27Mmedian roundNov 2026last seen
  4. 4AccelDeploying nowVC firm · United States1,341$32Mmedian roundNov 2026last seen
  5. 5Khosla VenturesDeploying nowVC firm · United States1,128$26Mmedian roundNov 2026last seen
  6. 6Intel CapitalDeploying nowCorporate VC · United States1,123$22Mmedian roundOct 2026last seen
  7. 7Norwest Venture PartnersDeploying nowVC firm · United States705$25Mmedian roundOct 2026last seen
  8. 8Salesforce VenturesDeploying nowCorporate VC · United States649$26Mmedian roundNov 2026last seen
  9. 9VenrockDeploying nowVC firm · United States560$36Mmedian roundOct 2026last seen
  10. 10Bain Capital VenturesDeploying nowVC firm · United States524$27Mmedian roundNov 2026last seen
  11. 11Madrona Venture GroupDeploying nowVC firm · United States435$14Mmedian roundNov 2026last seen
  12. 12RA Capital ManagementDeploying nowPrivate equity · United States395$93Mmedian roundNov 2026last seen
  13. 13Temasek HoldingsDeploying nowVC firm · Singapore384$100Mmedian roundOct 2026last seen
  14. 14ARCH Venture PartnersDeploying nowVC firm · United States337$74Mmedian roundOct 2026last seen
  15. 15HeadlineDeploying nowVC firm · United States307$15Mmedian roundOct 2026last seen
  16. 16Abstract VenturesDeploying nowVC firm · United States295$13Mmedian roundNov 2026last seen
  17. 17Craft VenturesDeploying nowVC firm · United States283$14Mmedian roundOct 2026last seen
  18. 18NorthzoneDeploying nowVC firm · United Kingdom240$22Mmedian roundOct 2026last seen
  19. 19CreandumDeploying nowVC firm · Sweden224$20Mmedian roundOct 2026last seen
  20. 20Perceptive AdvisorsDeploying nowAsset manager · United States206$100Mmedian roundOct 2026last seen
  21. 21Novo HoldingsDeploying nowVC firm · Denmark203$60Mmedian roundOct 2026last seen
  22. 22DeerfieldDeploying nowVC firm · United States198$50Mmedian roundOct 2026last seen
  23. 23Franklin TempletonDeploying nowPrivate equity · United States198$64Mmedian roundNov 2026last seen
  24. 24RTP GlobalDeploying nowVC firm · United States183$10Mmedian roundSept 2026last seen
  25. 25Wellington PartnersDeploying nowVC firm · Germany180$33Mmedian roundJun 2026last seen
53 more on this list

All 78 are in the app, with filters for stage, sector and market. A free account shows 10 per search, Pro up to 1,000.

See the whole list →

Reading for founders at Series B and scaling

More books for founders and investors on the Reading List.

As an Amazon Associate we earn from qualifying purchases.

Quick answers about series B genomics investors

Who are the most active series B genomics investors?

By cheques observed, the most active are Andreessen Horowitz, New Enterprise Associates, General Catalyst, Accel and Khosla Ventures.

How many series B genomics investors are there?

78 are on record. 90% made an investment in the last 12 months and 78% have led a round.

Which stages do series B genomics investors back?

Of the rounds with a named stage in the last 12 months, mostly Series A (26%) and Seed (20%).

How big are the rounds series B genomics investors join?

The typical (median) round among the leading investors here is $27M.

Which sectors do series B genomics investors back most?

In the last 12 months, mostly AI, Biotech and Healthcare.

Which series B genomics investors lead the most rounds?

Andreessen Horowitz (114 led), Accel (103 led) and General Catalyst (97 led).

Where are series B genomics investors based?

Most of the leading investors here are based in the United States (20 of the top 25); the rest in Singapore and the United Kingdom.

What have series B genomics investors invested in recently?

Recent rounds include LionBio Therapeutics (Pre-seed, Nov 2026, with South Park Commons), Thinking Machines Lab (Other, Nov 2026, with Accel) and T-Therapeutics (Series B, Nov 2026, with Eli Lilly).

Built from the rounds we watched, refreshed every night. How we count · Report a correction